Literature DB >> 24271361

Association of high-sensitivity assayed troponin I with cardiovascular phenotypes in the general population: the population-based Gutenberg health study.

Christoph Sinning1, Till Keller, Tanja Zeller, Francisco Ojeda, Michael Schlüter, Renate Schnabel, Edith Lubos, Christoph Bickel, Karl J Lackner, Patrick Diemert, Thomas Munzel, Stefan Blankenberg, Philipp S Wild.   

Abstract

BACKGROUND: Aim of the study was to analyze the correlation of high-sensitivity assayed troponin I with cardiac and vascular structure and function in a large population-based cohort.
METHODS: In a sample of 4,139 subjects (2,099 men, 2,040 women, age 35-74 years) from the population-based Gutenberg Health Study, troponin I was measured with a high-sensitivity assay that had a limit of detection of 1.9 pg/mL.
RESULTS: In the study cohort, 3,405 subjects had detectable troponin I concentrations [82.3% overall, 89.9% men (N = 1,888), 74.4% women (N = 1,517)]. All analyses were adjusted for age. The strongest correlate between detectable troponin I and measures of cardiac phenotypes was observed for left ventricular mass (p < 0.001) and left ventricular end-diastolic diameter (p < 0.001) for both, women and men. Left ventricular ejection fraction was inversely correlated with troponin I (p value <0.001 in men and 0.0013 in women), also measures of diastolic dysfunction as represented by Tei index and E/E' correlated with detectable troponin I concentrations (p < 0.001 for both gender). With respect to vascular structure and function, troponin I correlated with mean intima-media thickness of the carotid artery (p < 0.001 in men and p = 0.013 in women) but showed only borderline correlation with measures of vascular function represented by flow-mediated dilation (p = 0.05 in women and p = 0.018 in men) and arterial stiffness.
CONCLUSIONS: Troponin I assessed by a high-sensitivity assay correlated with measures of left ventricular hypertrophy and systolic and diastolic function, whereas its correlation with vascular phenotypes was only of weak magnitude.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24271361     DOI: 10.1007/s00392-013-0640-8

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  42 in total

1.  Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study.

Authors:  Philipp S Wild; Christoph R Sinning; Alexander Roth; Sandra Wilde; Renate B Schnabel; Edith Lubos; Tanja Zeller; Till Keller; Karl J Lackner; Maria Blettner; Ramachandran S Vasan; Thomas Münzel; Stefan Blankenberg
Journal:  Circ Cardiovasc Imaging       Date:  2010-07-19       Impact factor: 7.792

2.  High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission.

Authors:  Evangelos Giannitsis; Meike Becker; Kerstin Kurz; Georg Hess; Dietmar Zdunek; Hugo A Katus
Journal:  Clin Chem       Date:  2010-02-18       Impact factor: 8.327

3.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.

Authors:  Christopher R deFilippi; James A de Lemos; Robert H Christenson; John S Gottdiener; Willem J Kop; Min Zhan; Stephen L Seliger
Journal:  JAMA       Date:  2010-11-15       Impact factor: 56.272

4.  Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.

Authors:  Justin T Saunders; Vijay Nambi; James A de Lemos; Lloyd E Chambless; Salim S Virani; Eric Boerwinkle; Ron C Hoogeveen; Xiaoxi Liu; Brad C Astor; Thomas H Mosley; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Christie M Ballantyne
Journal:  Circulation       Date:  2011-03-21       Impact factor: 29.690

5.  Comparison of the new high sensitive cardiac troponin T with myoglobin, h-FABP and cTnT for early identification of myocardial necrosis in the acute coronary syndrome.

Authors:  Kerstin Kurz; Evangelos Giannitsis; Maike Becker; Georg Hess; Dietmar Zdunek; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2010-09-18       Impact factor: 5.460

6.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction.

Authors:  Till Keller; Tanja Zeller; Dirk Peetz; Stergios Tzikas; Alexander Roth; Ewa Czyz; Christoph Bickel; Stephan Baldus; Ascan Warnholtz; Meike Fröhlich; Christoph R Sinning; Medea S Eleftheriadis; Philipp S Wild; Renate B Schnabel; Edith Lubos; Nicole Jachmann; Sabine Genth-Zotz; Felix Post; Viviane Nicaud; Laurence Tiret; Karl J Lackner; Thomas F Münzel; Stefan Blankenberg
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

7.  Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project.

Authors:  Stefan Blankenberg; Tanja Zeller; Olli Saarela; Aki S Havulinna; Frank Kee; Hugh Tunstall-Pedoe; Kari Kuulasmaa; John Yarnell; Renate B Schnabel; Philipp S Wild; Thomas F Münzel; Karl J Lackner; Laurence Tiret; Alun Evans; Veikko Salomaa
Journal:  Circulation       Date:  2010-05-24       Impact factor: 29.690

8.  High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study.

Authors:  Wilfried Dinh; Werner Nickl; Reiner Füth; Mark Lankisch; Georg Hess; Dietmar Zdunek; Thomas Scheffold; Michael Coll Barroso; Klaus Tiroch; Dan Ziegler; Melchior Seyfarth
Journal:  BMC Cardiovasc Disord       Date:  2011-07-05       Impact factor: 2.298

9.  High population prevalence of cardiac troponin I measured by a high-sensitivity assay and cardiovascular risk estimation: the MORGAM Biomarker Project Scottish Cohort.

Authors:  Tanja Zeller; Hugh Tunstall-Pedoe; Olli Saarela; Francisco Ojeda; Renate B Schnabel; Tarja Tuovinen; Mark Woodward; Allan Struthers; Maria Hughes; Frank Kee; Veikko Salomaa; Kari Kuulasmaa; Stefan Blankenberg
Journal:  Eur Heart J       Date:  2013-10-08       Impact factor: 29.983

10.  Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

Authors:  Kunihiro Matsushita; Bakhtawar K Mahmoodi; Mark Woodward; Jonathan R Emberson; Tazeen H Jafar; Sun Ha Jee; Kevan R Polkinghorne; Anoop Shankar; David H Smith; Marcello Tonelli; David G Warnock; Chi-Pang Wen; Josef Coresh; Ron T Gansevoort; Brenda R Hemmelgarn; Andrew S Levey
Journal:  JAMA       Date:  2012-05-09       Impact factor: 56.272

View more
  12 in total

Review 1.  Investigating the role of acute mental stress on endothelial dysfunction: a systematic review and meta-analysis.

Authors:  Yi-Tao Xue; Qi-Wen Tan; Ping Li; Shan-Fang Mou; Shu-Juan Liu; Yue Bao; Hua-Chen Jiao; Wen-Ge Su
Journal:  Clin Res Cardiol       Date:  2014-11-13       Impact factor: 5.460

Review 2.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

3.  Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population.

Authors:  Matthias Bossard; Sébastien Thériault; Stefanie Aeschbacher; Tobias Schoen; Seraina Kunz; Mirco von Rotz; Joel Estis; John Todd; Martin Risch; Christian Mueller; Lorenz Risch; Guillaume Paré; David Conen
Journal:  Clin Res Cardiol       Date:  2016-08-17       Impact factor: 5.460

4.  Association of multiple biomarkers and classical risk factors with early carotid atherosclerosis: results from the Gutenberg Health Study.

Authors:  Christoph Sinning; Arne Kieback; Philipp S Wild; Renate B Schnabel; Francisco Ojeda; Sebastian Appelbaum; Tanja Zeller; Edith Lubos; Edzard Schwedhelm; Karl J Lackner; Eike S Debus; Thomas Munzel; Stefan Blankenberg; Christine Espinola-Klein
Journal:  Clin Res Cardiol       Date:  2014-02-02       Impact factor: 5.460

Review 5.  High-sensitivity cardiac troponin testing in routine practice: economic and organizational advantages.

Authors:  Claudio Galli; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2016-07

6.  Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium.

Authors:  Stefan Blankenberg; Veikko Salomaa; Nataliya Makarova; Francisco Ojeda; Philipp Wild; Karl J Lackner; Torben Jørgensen; Barbara Thorand; Annette Peters; Matthias Nauck; Astrid Petersmann; Erkki Vartiainen; Giovanni Veronesi; Paolo Brambilla; Simona Costanzo; Licia Iacoviello; Gerard Linden; John Yarnell; Christopher C Patterson; Brendan M Everett; Paul M Ridker; Jukka Kontto; Renate B Schnabel; Wolfgang Koenig; Frank Kee; Tanja Zeller; Kari Kuulasmaa
Journal:  Eur Heart J       Date:  2016-05-12       Impact factor: 29.983

7.  High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes.

Authors:  Ayman Samman Tahhan; Pratik Sandesara; Salim S Hayek; Muhammad Hammadah; Ayman Alkhoder; Heval M Kelli; Matthew Topel; Wesley T O'Neal; Nima Ghasemzadeh; Yi-An Ko; Mohamad Mazen Gafeer; Naser Abdelhadi; Fahad Choudhary; Keyur Patel; Agim Beshiri; Gillian Murtagh; Jonathan Kim; Peter Wilson; Leslee Shaw; Viola Vaccarino; Stephen E Epstein; Laurence Sperling; Arshed A Quyyumi
Journal:  J Am Heart Assoc       Date:  2018-02-21       Impact factor: 5.501

8.  Coronary Vascular Function and Cardiomyocyte Injury: A Report From the WISE-CVD.

Authors:  Ahmed AlBadri; Janet Wei; Odayme Quesada; Puja K Mehta; Yi Xiao; Yi-An Ko; R David Anderson; John Petersen; Babak Azarbal; Bruce Samuels; Timothy D Henry; Galen Cook-Wiens; Eileen M Handberg; Jennifer Van Eyk; Carl J Pepine; C Noel Bairey Merz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-10-08       Impact factor: 10.514

9.  The value of noncoronary atherosclerosis for identifying coronary artery disease: results of the Leipzig LIFE Heart Study.

Authors:  Alexander Weissgerber; Markus Scholz; Andrej Teren; Marcus Sandri; Daniel Teupser; Stephan Gielen; Joachim Thiery; Gerhard Schuler; Frank Beutner
Journal:  Clin Res Cardiol       Date:  2015-09-11       Impact factor: 5.460

10.  Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease.

Authors:  Ahmed Al-Badri; Ayman Samman Tahhan; Nabil Sabbak; Ayman Alkhoder; Chang Liu; Yi-An Ko; Viola Vaccarino; Afif Martini; Arianna Sidoti; Cydney Goodwin; Bahjat Ghazzal; Agim Beshiri; Gillian Murtagh; Puja K Mehta; Arshed A Quyyumi
Journal:  J Am Heart Assoc       Date:  2020-04-17       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.